We are live on ! Find out more
MVM

Medicxi Ventures Management Portfolio holdings

AUM $177M
1-Year Est. Return 212.06%
This Fund
S&P 500
This Quarter Est. Return
+1.54%
1 Year Est. Return
+212.06%
3 Year Est. Return
+504.78%
5 Year Est. Return
+412.43%
10 Year Est. Return
–
AUM
$427M
AUM Growth
-$10.4M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
–
Reduced
–
Closed
–

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CNTA
1
DELISTED
Centessa Pharmaceuticals
CNTA
$262M 61.4%
19,963,157
– –
PHAT icon
2
Phathom Pharmaceuticals
PHAT
$769M
$71.6M 16.75%
7,464,572
– –
NAMS icon
3
NewAmsterdam Pharma
NAMS
$3.04B
$52M 12.16%
2,869,565
– –
RAPT
4
DELISTED
RAPT Therapeutics
RAPT
$22.4M 5.23%
2,794,000
– –
AURA icon
5
Aura Biosciences
AURA
$784M
$19M 4.45%
3,039,892
– –

Similar funds

BFAG
Blackston Financial Advisory Group The Villages, Florida $177M AUM 21.44% 1-Year Est. Return
CMP
Christine Messmer PC Collegeville, Pennsylvania $177M AUM
JESC
J.E. Simmons & Co Dallas, Texas $177M AUM
OS
Objectivity Squared Charleston, South Carolina $178M AUM 31.14% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
RE
Rydar Equities Weatherford, Texas $178M AUM 29.33% 1-Year Est. Return
CSI
Cross Staff Investments Pittsford, New York $178M AUM 21.21% 1-Year Est. Return
RP
Regeneron Pharmaceuticals Tarrytown, New York $177M AUM 9.82% 1-Year Est. Return

Medicxi Ventures Management's Q2 2025 Portfolio in Review

As of Q2 2025, Medicxi Ventures Management held 5 positions worth $427M, down 2.4% from $438M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2025: portfolio turnover was 0%. Medicxi Ventures Management opened no new positions and made no exits, leaving the 5-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Medicxi Ventures Management's ten largest holdings make up 100% of its $427M portfolio in Q2 2025.
  • Medicxi Ventures Management opened 0 new positions and closed 0 in Q2 2025.
  • Medicxi Ventures Management's portfolio value fell 2.4% quarter-over-quarter to $427M.

Based on Medicxi Ventures Management's 13F filing for Q2 2025, filed 8 Jul 2025.